TYME Technologies Inc.

📍 Bedminster, United States🗓 Founded 2011👥 10 employees💰 Last funded Feb 2021
Biotechnology Research🌐 tymeinc.com
Website LinkedIn
TYME is an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™) that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. The Company is currently focused on developing its novel compound, SM-88. The Company believes that early clinical results demonstrated by SM-88 in multiple advanced cancers, including pancreatic, prostate, sarcomas, and breast, reinforce the potential of our emerging CMBT™ pipeline. For more information about the Company, visit www.tymeinc.com.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in TYME Technologies Inc.?
TYME Technologies Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did TYME Technologies Inc. last raise funding?
The most recent investment in TYME Technologies Inc. recorded on gritt.io was in February 2021.
When was TYME Technologies Inc. founded?
TYME Technologies Inc. was founded in 2011.
What industry is TYME Technologies Inc. in?
TYME Technologies Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TYME Technologies Inc. based?
TYME Technologies Inc. is headquartered in Bedminster, United States.